Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INSIDE Glioblastoma
2016-004471-46Phase 3Terminated
- Sponsor
- Sahlgrenska University Hospital
- Start
- Jan 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of disulfiram and metformin in glioblastoma (GBM), sponsored by Sahlgrenska University Hospital. Primary endpoint: Tissue drug concentrations and target effects. Started Jan 2017; status: terminated.
02
Drugs
disulfirammetformin
03
Conditions
glioblastoma (GBM)
Beyond the preview
Go deeper on 2016-004471-46.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-004471-46.